chrisvoncsefalvay/vaers-outcomes huggingface dataset:
BURNING OF THE EYES; PRESSURE IN THE EARS; SORE THROAT; IRRITATION OF NASAL PASSAGES; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included: deep vein thrombosis (The patient stated he experienced the following events prior to vaccination. The patient felt something was pierced up through the body and right into the lung after he woke up from the nap. Patient went to dermatologist first thinking it was an insect since there was a mark on his calf. Dermatologist diagnosed patient with Deep vein thrombosis (DVT) and sent patient to emergency room (ER) immediately. Patient did not receive any procedures in ER. It was not concluded that he had any internal injury or internal bleeding.). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205AZ1A, and expiry: UNKNOWN) dose was not reported, administered on 14-JUN-2021 for prophylactic vaccination. Concomitant medications included warfarin for deep vein thrombosis. On an unspecified date, the patient experienced burning of the eyes, pressure in the ears, sore throat, and irritation of nasal passages. Laboratory data (dates unspecified) included: normalized ratio (NR: not provided) 1.8. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from burning of the eyes, pressure in the ears, sore throat, and irritation of nasal passages. This report was non-serious.
Patient states varying degrees of edema and redness at site since injection. Currently minimal swelling with very faint redness appx 70mm in diameter.
fleeting rash on face after vaccine-Rash continued to re surface for the next 48 hours
Patient walked into my pharmacy for Pfizer booster shot and she presented her vaccine information on the phone to pharmacy crew . She already received 2 Pfizer vaccinations on March followed by Moderna  on May.  The crew who helped patient failed to document her 3rd shot on the voucher that was created by us. I found out this was her 4th shot after I injected Pfizer booster shot.   I have been following up with her conditions all day, she has not complained any particular adverse effects  so far. I informed her to report back to me if there are any other adverse reactions that she might experience in the future.
Information has been received from a consumer concerning her daughter who on an unspecified date was vaccinated with MMR II. Concomitant suspect therapy included VARIVAX. The reporter stated that her daughter received all childhood vaccinations, including MMR II and VARIVAX and then, after received all the childhood vaccines, the patient had developed learning disabilities such as attention deficit / hyperactivity disorder, spelling, reading concentration, and language issues, and has signs of dyslexia. This is one of several reports received from the same source. Additional information is not expected.
Employee given FLULAVAL vaccine at 3p. 430p EE started to get itchy, red, hives throughout body, puffy face, eyes. Uvula edema. Seen in ED. Tx with SOLUMEDROL, BENADRYL and fluids. Given prescription for Predisone 40mg po X 4 days. BENADRYL 25mg po every 6hrs X 2 days. EE did not start prescriptions until after seen in EOHS next morning d/t fear of any affects while breastfeeding. EE started on Predisone 11/30 early afternoon. Hives and itching resolved 12/1. Residual puffy eyes on 12/3.
Third Pfizer COVID vaccination caused chills , urgent and explosive diarrhea, vomiting, cant keep anything down. Monitoring for dehydration
Arm swelled and knot formed.  It lasted nine months, including time I was abroad.  I developed anxiety, depression soon thereafter.  Finally diagnosed with idiopathic Parkinsons disease at age 41.  Dr believe I exhibited signs of Parkinsons long before diagnosis which was missed before.
Positive covid test; Slight fever; Sneezing; Cough; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (Sneezing), COUGH (Cough), COVID-19 (Positive covid test) and PYREXIA (Slight fever) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced SNEEZING (Sneezing), COUGH (Cough) and PYREXIA (Slight fever). On 27-Jan-2021, the patient experienced COVID-19 (Positive covid test). At the time of the report, SNEEZING (Sneezing), COUGH (Cough), COVID-19 (Positive covid test) and PYREXIA (Slight fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication nor treatment information provided
a sore throat; slight head acce; This spontaneous case was reported by a pharmacist and describes the occurrence of OROPHARYNGEAL PAIN (a sore throat) and HEADACHE (slight head acce) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (a sore throat) and HEADACHE (slight head acce). At the time of the report, OROPHARYNGEAL PAIN (a sore throat) and HEADACHE (slight head acce) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment medication use was not provided by the reporter.
-severe night sweats -elevated temperature of 100.9 -alternating between being very cold/shivering and being very hot/sweating -body/joint aches -involuntary full body tremors -loss of appetite -nausea -pounding headache -fatigue (slept the entire next day, had no energy to move at all) -shortness of breath
Shivering/chills; Ache; Tiredness; Painful arm; This non-serious case was reported by a consumer and described the occurrence of shivering in a 53-year-old male patient who received Herpes zoster (Shingrix) (batch number 559H5) for prophylaxis.   Concurrent medical conditions included hiv positive. Concomitant products included cobicistat + elvitegravir + emtricitabine + tenofovir alafenamide fumarate (Genvoya).   On 14-MAR-2023, the patient received Shingrix .5 ml. On 14-MAR-2023, less than a day after receiving Shingrix, the patient experienced shivering (Verbatim: Shivering/chills), pain (Verbatim: Ache), tiredness (Verbatim: Tiredness) and pain in arm (Verbatim: Painful arm). On 17-MAR-2023, the outcome of the shivering and pain were recovered/resolved (duration 3 days). The outcome of the tiredness and pain in arm were not recovered/not resolved.   It was unknown if the reporter considered the shivering, pain, tiredness and pain in arm to be related to Shingrix.     It was unknown if the company considered the shivering, pain, tiredness and pain in arm to be related to Shingrix.   Additional Information: GSK receipt date:19-MAR-2023 The patient was the reporter. The symptoms were not treated. The reporter stated that he was frightened for second shot.  The reporter consented to follow up.
She felt nauseous/She continued to feel nauseous for months and then it dissipated; She vomited.  She sat with a basin in case she vomited again; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (She felt nauseous/She continued to feel nauseous for months and then it dissipated) and VOMITING (She vomited.  She sat with a basin in case she vomited again) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced NAUSEA (She felt nauseous/She continued to feel nauseous for months and then it dissipated) and VOMITING (She vomited.  She sat with a basin in case she vomited again). At the time of the report, NAUSEA (She felt nauseous/She continued to feel nauseous for months and then it dissipated) and VOMITING (She vomited.  She sat with a basin in case she vomited again) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.
Tuesday - neck has locked up; Sunday (48 hrs) migraine (affected vision, hearing, nausea had pain of course); Sunday (48 hrs) migraine (affected vision, hearing, nausea had pain of course); Sunday (48 hrs) migraine (affected vision, hearing, nausea had pain of course); Sunday (48 hrs) migraine (affected vision, hearing, nausea had pain of course); Sunday (48 hrs) migraine (affected vision, hearing, nausea had pain of course); Friday evening - fever in arm, but otherwise good; Friday evening - fever in arm, but otherwise good; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 23Apr2021 at 14:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included bipolar disorder, migraine (1-2 per month) and irritable bowel syndrome (IBS). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included piroxicam (PAXIL), eszopiclone (LUNESTA), bupropion (BUPROPRION) and lamotrigine (MANUFACTURER UNKNOWN) for unknown indications from an unknown date and unknown if ongoing. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. On Friday evening 23Apr2021, the patient experienced fever in arm, but otherwise good. On Sunday (48 hrs) on 25Apr2021 at 16:00, the patient experienced migraine (affected vision, hearing, nausea had pain of course). On Monday 26Apr2021, the patient had another migraine (have never had 2 in a row same symptom but worse). On Tuesday 27Apr2021, the patient's neck had locked up. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever in arm, migraine (affected vision, hearing, nausea had pain of course), neck had locked up was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
31-year-old male with no reported past medical history was brought in by EMS actively receiving CPR.  EMS states patient's family noted patient's was running in the house for an unknown reason and then managed to wall, was noted not to have a pulse at that time, and family began CPR.  EMS also states upon arrival patient was noted to be in VFib received for shocks, epinephrine x4, bicarb x2, and Narcan 0.4 prior to arrival.  No other history obtained due to patient's medical condition at this time.  31-year-old male with no significant past medical history who received his booster dose of Pfizer COVID vaccination on Tuesday (12/21/21).  As per his wife, he continue to work out for his job during the week.  In the early hours of the morning, he suddenly woke up from sleep and was very restless and confused.  He was knocking things off the side of the bed and eventually stood up and walked into the wall and injured his nose.  Subsequently, he collapsed and had a witnessed cardiac arrest.  EMS arrived in approximately 5 minutes and he was noted to be in VFib cardiac arrest.  He had a very prolonged VFib arrest and required a total of 15 electric shocks combined between EMS and ER services.  He also had multiple rounds of epi.  He was eventually cardioverted to sinus rhythm.  On my arrival to bedside, he was tachypneic to mid 20s and currently on Versed and fentanyl infusions for sedation and dopamine at 10 mcg/k.  Chest x-ray shows diffuse bilateral lung infiltrates.   Status post cardiac arrest and ensuing cardiogenic shock: ROSC achieved after prolonged CPR.  Cardiology and EP consults were requested and Dr. agreed to perform an EP study to rule out a primary malignant cardiac arrhythmia as a potential etiology for his sudden cardiac arrest.  Primary cardiac etiologies such as myocarditis and congenital malignant arrhythmias should also be considered in the differential diagnosis.  Bedside echocardiogram showed a depressed EF of 15-20% with no significant RV dilatation.  Pulmonary embolism cannot be ruled out at this point.  Will start heparin and perform a CT angiogram of his lungs once he is hemodynamically stable.  Meanwhile, recommend starting therapeutic heparin infusion.  Continue cycle cardiac enzymes.  CT head and CT spine showed no acute pathologies. Urine tox screen pending.
couldn't sleep on that arm; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sleeplessness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sleeplessness (Verbatim: couldn't sleep on that arm). The outcome of the sleeplessness was recovered/resolved (duration 3 days).   It was unknown if the reporter considered the sleeplessness to be related to Shingles vaccine.     It was unknown if the company considered the sleeplessness to be related to Shingles vaccine.   Additional Information: GSK Receipt: 24-MAR-2023 The case was received from the patient via interactive digital media. The patient's physician recently recommended him or her get his or her second vaccination if shingles.  The patient could not sleep on that arm for 3 days. The follow-up could not be possible as no contact details were available.
pt recvd vax; had red spot on neck, chest, & legs; itching;
Person received the Covid vaccine at 9:50 am and within 1 minute after the injections, patient appeared confused and was shanking, had a 2 convulsions while sitting in the chair that lasted 1 second each. Patient stated " I don't know where I am". Patient lowered to the ground, face mask removed. Patient systolic blood pressure was 110 during the episode with HR 56, pulse O2 98% room air. After approximately 4-5 minutes patients stated "I'm feeling ok now" is alert and oriented to self, place and time. Dr. assisted the patient, orange juice given to the patient. At 10:30am patient back to her baseline, no distress noted and discharged home, no distress at the discharge time.
MMRV and Varicella was given. No adverse effects at this point in time.
Got more sick than normal; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 63 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 03May2021 10:00 (Lot number: EW0164) at the age of 63 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Glaucoma" (ongoing), notes: Verbatim: Glaucoma, diagnosed with this condition in her 30's. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose: 1, Lot Number: ER8732), administration date: 12Apr2021, when the patient was 63 years old, for COVID-19 immunization; Flu (Adverse Event: Feeling a little icky after a flu shot.), reaction(s): "Feeling a little icky". The following information was reported: ILLNESS (non-serious) with onset 03May2021, outcome "recovered", described as "Got more sick than normal". Therapeutic measures were not taken as a result of illness.  Additional Information: The patient's weight (65.77 kg) and height (168 cm) was reported. Patient concomitant medications included antidepressant, anti-anxiety, Glaucoma drops, Heartburn pill (takes this once in a while) and Allergy pill (Start: Unspecified Stop: Unspecified). Patient states that she had the first one and everything was fine.  With the second one she got more sick than normal, stated that she got the second vaccine in the morning, probably around 0800 and started to feel sick that same night. States that she actually probably got the vaccine around 1000.  States she was sick for a long time, probably like a week or so, then recuperated  Now, knowing that the booster dose is something you have to have she was wondering what she should do and states that with how sick she felt after the second one she needs some advice,  The patient denies any labs, testing, or treatments relevant to these events.  No follow-up attempts are possible. No further information is expected.
Injection site pain, lethargic, headache, chills, muscle/joint pain, sore throat; increased severity of chronic tinnitus
Extreme side effects; A spontaneous report was received from a consumer concerning a  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events extreme side effects.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 22 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) unknown route of administration in the unknown site for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced extreme side effects.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event, extreme side effects was unknown.
Cancer; This spontaneous case was reported by a patient family member or friend and describes the occurrence of NEOPLASM MALIGNANT (Cancer) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced NEOPLASM MALIGNANT (Cancer) (seriousness criteria death and medically significant). The reported cause of death was Cancer. It is unknown if an autopsy was performed.            It was unknown that patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Concomitant medication details not reported by the reporter.  Suspect vaccine dosage text was reported as unknown.  It was reported that the Moderna Covid-19 caused cancer in 25 patients who were the friends of reporter. The patient will not provide any additional information on these patients. It was also reported that the those patients who died were killed by the Moderna Covid-19 vaccine because Moderna vaccine is poison Cancer rates for jabbed Moderna Cancer patients was up 300% The Doctors are part of the Kabal along with Moderna.  Treatment details was not reported by the reporter.  This case contains information about 11th patient out of 25 patients.  Company comment:  This is a spontaneous case concerning a patient of unknown age and gender, with no reported medical history, who experienced the unexpected serious (death and medically significant) event of Neoplasm malignant. Latency is unknown but it was reported that the patient developed cancer, with fatal outcome after the administration of mRNA-1273.222 vaccine.  No further information was available in the report. It is unknown if an autopsy was performed.  The benefit-risk relationship of mRNA-1273.222 Vaccine is not affected by this report.     This case was linked to US-MODERNATX, INC.-MOD-2023-735987 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735987:Master case, Patient 1; Reported Cause(s) of Death: Cancer
Nine hours after the vaccine was administered I began to have symptoms.  It started with severe chills. I bundled up and went to bed.  I woke at about 2am with severe nausea. Went to the bathroom still suffering from chills, and in severe pain from joints and muscles attempted to use the toilet and passed out.  Revived and climbed back into bed.  The next day 01/16/21 continued to have chills, nausea, and joint and muscle pain.  At 2pm on 01/16/21 started to have a rash in my stomach.  By 8pm the rash was on my stomach, and back.  Sunday 01/17/21 still having mild chills and aches, the rash is now wide spread over my torso and back.
I experienced chest pains for a couplie of days then it felt like a heart attack, to the point my employer sent me to the doctor. I felt weak and tired, and experienced fatigue. I was told to take aspirin and rest.
The client came back to the health dept on Monday, 11/5/01. She states that on Saturday, she felt achy and just "not right". Then she woke up on Monday morning and had a large red spot approx. 3-4" below the injection site. The client states that the same thing happened after her last pneumonia and tetanus shots. Instructed her to notify physician and to take Benadryl to see if that helps.
I did not have an adverse reaction to the vaccine. For a couple of days prior to testing positive for COVID-19 I had congestion. On 03/16/2023, I had severe chills and fever. I tested positive for COVID-19 on 03/17/2023. I contacted my doctor and got a prescription for Paxlovid. I lost my sense of taste, body aches and fatigue. I tolerated the medication without any issues. As of today, I still have congestion and tired or washed out.
Recovering from concussion; This is a spontaneous report received from a contactable reporter(s) (Nurse), Program ID: The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE:2, Single, Unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (DOSE:1, Single, Unknown manufacturer), for COVID-19 immunization. The following information was reported: CONCUSSION (non-serious), outcome "unknown", described as "Recovering from concussion". Additional Information: Reaction / Event as Reported. Recovering from concussion. Outcome of reaction/event at the time of last observation was (UNKNOWN). Batch/lot number was Not Provided. System Reference was reported. Details mentioned as: 159558 Pfizer. NDC number of Pfizer COVID vaccine booster was Not Provided. Reason for no lot number of Pfizer COVID vaccine booster was provided as Caller unwilling to complete the report. Expiry Date of Pfizer COVID vaccine booster was Not Provided. Additional Context was reported as, She has a patient on the line who is already done with first booster dose of the Pfizer COVID 19 vaccine and is due to get 2nd booster dose, however, she is recovering from a concussion, and she also wanted to know if there are any side effects in her brain from getting the 2nd booster dose. Caller confirmed information above and stated she did not wish to create report.  She did not want to provide an email or date of birth and requested to be transferred to have her question answered. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.